Fosun Health Group plans to build its first overseas hospitals in Indonesia. This move marks a major step in Chinese healthcare firms’ global expansion. Moreover, it reflects growing confidence in Southeast Asia’s medical market potential.
The decision highlights Indonesia’s strong appeal. Not only does it have 287 million people—the world’s fourth-largest population—but Beijing also actively encourages its healthcare sector to “go global.” Therefore, the timing aligns with both national strategy and market opportunity.
At the SCMP’s China Conference: Southeast Asia 2026 in Jakarta, CEO Frank Hu Hang confirmed the plan. Specifically, he said Fosun intends to open “several hospitals” across the country.
“We’ve signed term sheets with local partners,” Hu told the SCMP. “However, we haven’t formally signed contracts yet.” He did not disclose the number of hospitals or their exact locations.
In addition, Fosun is exploring partnerships with local distributors to sell its medical products. Furthermore, the company plans to deepen collaboration with Indonesian manufacturers to support long-term operations.
Fosun Health was founded in 2010 in Shanghai. As of June 2025, it operated 19 hospitals, clinics, and diagnostics centres in mainland China. Recently, it has accelerated its international efforts. For instance, it has held preliminary talks about entering Bangladesh and Mongolia as well.
Fosun is not alone in this strategy. Several Chinese healthcare companies are now targeting regions like Southeast Asia and the Middle East. Why? Because these areas host large Chinese communities and suffer from fragmented, under-resourced health systems.
Hu emphasized Indonesia’s critical shortage of medical professionals. Currently, there are only 0.6 doctors per 1,000 people—far below global standards. Consequently, this gap creates a compelling case for high-quality foreign investment.
During a panel on supply chains, Hu noted that Fosun’s experience with internet-based medical services in China could benefit Indonesian patients. He urged the government to digitise health and logistics systems faster. In particular, he suggested using China’s digital infrastructure as a model.
He also called for consistent and predictable government policies. After all, policy stability is essential to attract long-term investors. Without it, even promising projects may stall.
“I think there will be more opportunities between our group and partners in Indonesia,” Hu said confidently.
With its vast population, rising demand, and digital potential, Indonesia is emerging as a key hub for global health innovation. For Fosun, this expansion represents more than business growth—it offers a chance to shape the future of care in the region. Through Fosun Health Indonesia, the company aims to deliver integrated, tech-enabled services that meet both patient needs and national health goals.
READ: Chronic Kidney Disease Affects 24 Million Nigerians, Experts Warn
